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We evaluated a ‘see and treat’ procedure involving screening, colposcopy, biopsy and cryotherapy by trained nurses in one-visit in
field clinics in a cervical screening study in South India for its acceptability, safety and effectiveness in curing cervical intraepithelial
neoplasia (CIN). Women positive on visual inspection with acetic acid (VIA) were advised colposcopy, directed biopsies and
cryotherapy if they had colposcopic impression of CIN in one visit by nurses in field clinics supervised by a doctor. Side effects and
complications were assessed and cure rates were evaluated with VIA, colposcopy and biopsy if colposcopic abnormalities were
suspected. Cure was defined as no clinical or histological evidence of CIN at X6 months from treatment. Of the 2513 women
offered ‘see and treat’ procedure, 1879 (74.8%) accepted. Of the 1397 women with histologically proved CIN treated with
cryotherapy, 1026 reported for follow-up evaluation. Cure rates were 81.4% (752 out of 924) for women with CIN 1; 71.4% (55 out
of 77) for CIN 2 and 68.0% (17 out of 25) for CIN 3. Minor side effects and complications were documented in less than 3% of
women. ‘See and treat’ with cryotherapy by nurses under medical supervision is acceptable, safe and effective for cervical cancer
prevention in low-resource settings.
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Cryotherapy offers an effective and simple outpatient treatment for
women with cervical intraepithelial neoplasia (CIN) (Alliance for
Cervical Cancer Prevention, 2003; Sellors and Sankaranarayanan,
2003). The currently available data on its effectiveness, safety
and acceptability are based on treatment provided by medical
doctors in developed countries (Alliance for Cervical Cancer
Prevention, 2003). The evidence from such published studies
indicate that cryotherapy is an effective, safe and acceptable
treatment and cure rates exceed 86% for women with CIN confined
to the ectocervix (Alliance for Cervical Cancer Prevention, 2003).
However, it is not clear if similar cure rates can be achieved for
cryotherapy provided by trained nurses in field conditions in less
developed countries.
‘See and treat’ usually involves a loop electrosurgical excision
procedure (LEEP) simultaneously to diagnose and to treat pre-
malignant cervical disease in screen-positive women in one visit
thereby eliminating the need of a second visit for treatment (Ferris
et al, 1996). We adapted the ‘see and treat’ principles to achieve
maximum compliance of screen-positive women for diagnosis and
cryotherapy in one visit within the context of a randomised
controlled screening trial in South India designed to evaluate the
impact of visual inspection with acetic acid (VIA) on cervical
cancer incidence and mortality (Sankaranarayanan et al, 2004).
The screening trial, a collaborative research project of the
Christian Fellowship Community Health Centre (CFCHC), Ambil-
likai, in Dindigul district, Tamil Nadu, India and the International
Agency for Research on Cancer (IARC), Lyon, France, was
reviewed and approved by the institutional ethical review
committees of both CFCHC and IARC. The design, methodology
and the preliminary results of the trial have been published
elsewhere (Sankaranarayanan et al, 2004, 2005). In this paper, we
describe the acceptability, safety and effectiveness of ‘see and treat’
procedure involving screening, colposcopy, directed biopsy and
double-freeze cryotherapy by trained nurses in a single-visit in
field clinics supervised by a doctor.
MATERIALS AND METHODS
Participants
Apparently healthy women aged 30–59 years, with an intact uterus
and no past history of cervical neoplasia in clusters of villages
randomised to the screening group were identified by active
enumeration of households. Female health workers explained
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sthe study and the risk factors, prevention, early detection
and treatment of cervical cancer to eligible women. A printed
consent form was read out and signature, or left thumb
impression, of willing eligible women was obtained in the presence
of a witness.
Training of nurses in VIA, colposcopy and cryotherapy
Eight registered nurses with 3 years’ nursing education learned
VIA, colposcopy and cryotherapy in a 3-week intensive training
course, using manuals prepared by the IARC (Sankaranarayanan
and Wesley, 2003; Sellors and Sankaranarayanan, 2003). Training
included lectures, discussions, review of photographs of normal
and abnormal cervix, and clinical sessions to observe and practice
VIA, colposcopy, directing biopsy and cryotherapy, initially under
the supervision of the teaching faculty and then independent
assessment with the findings checked by the faculty.
The training allowed the nurses to develop skills in obtaining
gynaecological history, visualising the cervix to recognise the
squamocolumnar junction (SCJ), transformation zone (TZ),
assessing the TZ with acetic acid and Lugol’s iodine, in recognising
acetowhite and mustard-yellow lesions, directing biopsies, in
discussing results and management plans with women, in
performing cryotherapy and in counseling women on follow-up
care. Their performance was routinely monitored by regular
review of screen-positive rates, correlation between colposcopy
and histology findings, and routine medical supervision in the
field. Refresher courses were conducted every 3 months to
maintain competency.
Screening, colposcopy and directed biopsy
The women were invited for VIA screening in field clinics
organised in village primary health centres, municipal offices,
schools, or women’s club buildings. A medical doctor (gynaeco-
logist or clinical oncologist or general practitioner) was always
present and supervised the functioning of the field clinic. The
nurses consulted the doctor whenever in doubt or if they required
assistance. During screening clinics the nurse exposed and
examined the cervix using a speculum and bright halogen focus
lamp. Acetic acid (4%) was applied to the cervix using a cotton
swab and VIA findings were reported 1min after the application
as negative or positive (Sankaranarayanan and Wesley, 2003). Test
results were explained to women and VIA-negative women were
reassured and medication was prescribed if they suffered from
cervical inflammation.
Nurses offered VIA-positive women immediate ‘see and treat’
involving colposcopy, directed biopsy for women with colposcopic
impression of precancerous lesions followed by treatment with
cryotherapy. Colposcopy was carried out with a binocular
colposcope using 6–12 magnification, under the supervision of a
medical officer. The nurses followed the steps described in the
IARC manual on colposcopy (Sellors and Sankaranarayanan,
2003). If the SCJ was not visible in its entirety, even after
manipulation of the endocervical canal, colposcopy was termed as
unsatisfactory and those women were referred to doctors for
further assessment.
In women with visible SCJ, a colposcopic impression was
made in terms of normal, benign abnormalities (such as ectropion,
cervicitis, atrophy, polyp), low- or high-grade lesion and
invasive cancer, based on colour tone, margins and surface
characteristics of acetowhite lesions, vascular features, such as
punctuation, mosaics in the acetowhite lesions; atypical vessels,
growth if any and appearance following application of Lugol’s
iodine (Sellors and Sankaranarayanan, 2003). Punch biopsies
were obtained from the worst of any abnormal areas under
colposcopic guidance.
Cryotherapy
Women with colposcopic impression of low- or high-grade lesions
were advised immediate cryotherapy after a directed biopsy, when
all the following criteria were met:
 The lesion involved less than three quadrants of the TZ;
 No extension of the lesion into the endocervical canal;
 No extension of the lesion onto the vaginal walls;
 Entire lesion could be covered by the cryoprobe
 SCJ was visible in its entirety;
 No clinical or colposcopic suspicion of invasive cancer.
Women with extensive ectropion or chronic cervicitis without
colposcopic features of CIN were also encouraged to undergo
cryotherapy, after taking a punch biopsy. Women with lesions
not eligible for cryotherapy were referred to the CFCHC for LEEP
or cold knife conisation.
Before treatment, nurses explained colposcopy results and cryo-
therapy procedure, potential benefits, side effects and complica-
tions and encouraged the woman to accept immediate treatment.
Cryotherapy was performed using nitrous oxide refrigerant, with
a 20–24mm ectocervical cryoprobe tip with a shallow nipple by
standard double-freeze technique as described in the IARC manual
(Sellors and Sankaranarayanan, 2003). Cryotherapy equipment,
made in India, was used. No local anaesthesia, sedation or
analgesics were used.
The cryoprobe tip, washed with saline, was firmly applied on the
cervix to ensure adequate thermal contact. Cryotherapy involved
two sequential freeze–thaw cycles, each one consisting of a 3-min
freeze followed by 5min of thawing (3-min freeze, 5-min thaw,
3-min freeze). Ice ball formation on the cryoprobe and on the
cervix during the procedure was closely observed to ensure the tip
did not inadvertently contact and freeze any part of the vagina
during the procedure.
Once the second freeze for 3min was completed, adequate time
was allowed for thawing before removing the probe from the cervix
by gentle semicircular movements. The cervix and vagina were
then examined for any bleeding, particularly from the biopsy site
or for any accidental vaginal freezing. The vagina was not packed
with gauze after cryotherapy to allow secretions to escape. Women
were provided with a supply of sanitary pads to prevent staining
their clothes.
Supportive care and instructions following cryotherapy
Women were given home-care instructions and were informed that
they could experience some mild cramps and a clear or lightly
bloodstained watery discharge for up to 4–6 weeks after treatment.
They were advised not to use vaginal douche or tampons, or to
have sexual intercourse for 1 month after treatment. They were
advised to report back to the clinic if they experienced any of the
following symptoms during the 4 weeks after treatment: fever X2
days, severe lower abdominal pain, foul-smelling greenish yellow
discharge, bleeding with clots or bleeding for over 2 days. All
treated women received presumptive antibiotic treatment with oral
metronidazole and doxycycline for 5 days. They were prescribed
oral paracetamol for any mild pain or cramps experienced after
treatment.
Processing of biopsy and histology reporting
Biopsy specimens were processed in the screening project
pathology laboratory and the slides were reported on by the
pathologists at the PSG Institute of Medical Sciences and Research,
Coimbatore, India. As part of quality assurance, processing of
specimens in the laboratory, laboratory manuals, and reporting
procedures were periodically reviewed, and technicians and
pathologists were re-trained. A sample of slides was reviewed for
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Trivandrum, India and University of Lyon, France.
Follow-up of women treated with cryotherapy
Each woman treated for CIN was given an appointment for a
follow-up visit 1-year after treatment to assess the cervix and to
rule out cervical neoplasia, but some reported early for follow-up
evaluation. All those who reported earlier than 6 months after
treatment and never came afterwards were considered as ‘lost to
follow-up’. At follow-up clinics, again supervised by medical
doctors, VIA and colposcopy were carried out by nurses and
biopsies were directed from colposcopically abnormal areas.
Women with confirmed disease at follow-up were treated with
repeat cryotherapy or excision treatment depending upon the
lesion characteristics.
Evaluation of outcomes: cure rates, side effects and
complications
The outcome of evaluation at follow-up was defined as ‘cure’ if no
CIN lesions were established histologically if a biopsy specimen
was obtained or no colposcopic features of CIN were demonstrated
in cases without biopsy.
Mild pain or mild cramps during or after treatment, fainting
and flushing during or immediately after treatment, mild bleeding
or spotting immediately after treatment or malodorous excessive
discharge following treatment were assumed to be side effects and
as an indicator of acceptability (Alliance for Cervical Cancer
Prevention, 2003). Anaphylactic reactions during treatment, severe
pain, cramps or severe bleeding during or after cryotherapy
requiring further treatment, severe local cervical infections,
unintended surgery within 4 weeks following cryotherapy, pelvic
inflammatory disease, and functional cervical stenosis were
assumed to be complications of treatment and as an index of
safety of treatment (Alliance for Cervical Cancer Prevention, 2003).
Cure rates, side effects and complications were reported
as frequency percentages. Cure rates categorised by age, area
of lesion and grade of CIN were compared using w
2 statistic.
Role of the funding source
The funding source had no role in study design, data collection,
analysis and interpretation, writing of the report, or in the decision
to submit the report for publication.
RESULTS
Of the 2513 women treated with cryotherapy in our study, 1879
(74.8%) had it on the same day as screening, colposcopy and
directed biopsy; the remaining wanted to consult their family: 233
(9.3%) returned within 2 weeks to receive treatment, whereas 401
(15.9%) availed treatment after 2 weeks from screening and
colposcopy.
Colposcopic impression and histology of the 2513 women
treated with cryotherapy are given in Table 1 (Figure 1): 1397
(55.6%) had CIN (1242 CIN 1 and 155 CIN 2–3) on histology. The
12 women with subclinical invasive cancer who received cryo-
therapy were later referred for cancer treatment. Of the entire 1573
women with histologically confirmed CIN, 1397 (88.8%) had
cryotherapy, 88 (5.6%) had LEEP and only 82 (5.2%) did not avail
treatment in our study.
The distribution of follow-up times from the date of cryotherapy
for evaluation of cure rates are given in Table 2: 1026 women
(73%) reported for follow-up between 6 and 56 months and were
included for analysing the cure rates, side effects and complica-
tions of cryotherapy; 371 (27%) were lost to follow-up (Figure 1).
The mean follow-up duration was 27 months. The disease status at
follow-up was based on histology in 595 (58.0%) women and on
colposcopy in the remaining 431 (42.0%) women. The distribution
of follow-up status is given in Table 3: 824 (80.3%) women had no
evidence of CIN and were considered cured; the cure rate for
women with CIN 1 was 81.4 and 70.6% for women with CIN 2–3
lesions (p 0.009).
The follow-up status among 885 (86.3%) VIA-negative women
at follow-up evaluation is as follows: 789 were cured; CIN 1, 87;
CIN 2–3, 9; among 141 (13.7%) VIA-positive women: 35 were
cured; CIN 1, 92, CIN 2–3, 12; invasive cancer: 2. The sensitivity,
specificity, positive and negative predictive values of VIA detecting
CIN 2 or worse lesions at follow-up were 60.9, 87.3, 9.9 and 99.0%,
respectively. Cure rates of CIN according to age, area of cervix
involved and grade of the lesion are given in Table 4. Women with
CIN 2–3 had a significantly lower cure rate compared to those
with CIN 1. Age and area of lesion did not affect cure.
The following side effects were observed: mild pain or mild
cramps during or after treatment in 25 (2.1%) women; malodorous
excessive vaginal discharge following treatment in 19 (1.6%); mild
bleeding or spotting in nine (0.7%), delayed bleeding from the
biopsy site in three (0.2%), and fever in two (0.2%) women. The
following complications were recorded: local cervical infection in
14 women (1.4%), cervical tenderness in five (0.5%), severe pelvic
cramps and lower abdominal pain requiring parenteral medication
in one (0.1%) and one (0.1%) suffered from accidental vaginal
freezing. There were no instances of anaphylactic reactions, severe
bleeding requiring suturing or blood transfusion, unintended
surgeries or pelvic inflammatory disease requiring hospitalisation
or functional cervical stenosis.
DISCUSSION
Our findings have important implications for efficient service
delivery and cancer prevention in cervical screening programmes
in low- and medium-resourced settings. It indicates that nurses,
after adequate in-service training and under medical supervision,
can effectively perform screening, colposcopy, directing biopsies,
providing cryotherapy and follow-up evaluation.
Our findings confirm a ‘see and treat’ approach using cryo-
therapy by nurses is acceptable to women, safe and ensures
Table 1 Colposcopy and histology findings of 2513 women treated with cryotherapy
Histology at baseline (before cryotherapy)
Colposcopy impression at enrolment No evidence of CIN
a CIN 1 CIN 2 CIN 3 Cancer Total
Ectropion or cervicitis 260 81 3 3 0 347
Low-grade lesion 786 1051 87 31 8 1963
High-grade lesion 58 110 22 9 4 203
Total 1104 1242 112 43 12 2513
aCervical intraepithelial neoplasia.
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ssatisfactory participation of screen-positive women for diagnosis
and treatment. The ‘see and treat’ approach has been mainly
responsible for the high proportion of women with CIN receiving
treatment. The acceptance by three out of four women offered
the single visit ‘see and treat’ procedure and the fact that only a
negligible proportion of women with histologically confirmed CIN
did not avail treatment amply demonstrate the high acceptability
and usefulness of this approach in maximising treatment coverage.
It has been our policy to treat women with low-grade disease, as
our intervention is a once in a life-time and due to difficulties in
ensuring follow-up. Directed biopsy, taken just before cryotherapy,
has proved to be safe and has given a unique opportunity to
overcome two important limitations of cryotherapy, namely, lack
of histological proof of lesions treated and the risk of ignoring
those with occult invasive cervical cancers who received sub-
optimal treatment with cryotherapy.
That 60% of women with a colposcopic impression of a
precancerous lesion had a histologically confirmed CIN indicates
that nurses can provide reasonably competent colposcopy under
medical supervision. ‘See and treat’ with cryotherapy in our study
resulted in 40% of the women being unnecessarily treated and
12 (0.6%) had an occult invasive cancer frozen. The availability
of histology after treatment enabled these women to be treated
adequately. Even though, one fourth of the treated women could
not be evaluated for cure due to loss to follow-up, given the
difficulties in tracing women in developing countries, our follow-
up rates are satisfactory.
Adequate treatment of CIN is vital for the success of cervical
screening in preventing cervical cancer. Existing cervical screening
programmes in low- and medium-resource countries have been
less successful in reducing cervical cancer burden partly owing to
inadequate coverage of treatment of women detected with CIN
(Sankaranarayanan et al, 2001; IARC, 2004). Lack or inadequacy
of well-trained medical manpower for colposcopy and treatment
of CIN is a major resource constraint in many developing
countries (Sankaranarayanan et al, 2001). Well-trained nurses
provide alternative human resources for screening, colposcopy
and treatment by cryotherapy (Gifford and Stone, 1993; Hartz,
1995; Todd et al, 2002; Royal Thai College of Obstetricians and
Gynaecologists (RTCOG)/JHPIEGO Corporation Cervical Cancer
Prevention Group et al, 2003; Sankaranarayanan et al, 2004;
McPherson et al, 2005; Gage et al, 2006). There is some evidence
that colposcopy provided by nurses is as good as doctors and that
nurses are viable alternate providers (Gifford and Stone, 1993;
Hartz, 1995; Todd et al, 2002; McPherson et al, 2005; Gage et al,
2006). Nurse colposcopists have been introduced in countries
such as the US, UK and New Zealand in recent years.(Gifford and
Stone, 1993; Hartz, 1995; Todd et al, 2002; McPherson et al, 2005;
Gage et al, 2006).
There is enough evidence that cryotherapy provided by doctors
is an effective and safe procedure for treating CIN (Alliance for
Cervical Cancer Prevention, 2003). However, there is only limited
Table 2 Details of follow-up of women with CIN treated with
cryotherapy
Histology at baseline
(before cryotherapy)
Follow-up after cryotherapy CIN
a 1 CIN 2 CIN 3 Total
No follow-up 316 35 18 369
Less than 6 months 2 0 0 2
7 Months or more 924 77 25 1026
Total 1242 112 43 1397
aCervical intraepithelial neoplasia.
2166 women aged  
30–59 years with 
colposcopic features of 
CIN 
347 women aged 30–59  
years with colposcopic 
features of ectropion or 
inflammation 
2513 women 
Punch biopsy by nurses 
Double-freeze cryotherapy by nurses 
1104 women (43.9%) 
with no CIN 
1397 women (55.6%) 
with histology 
confirmed CIN 
1026 women  
followed up at 6 months +
371 women 
lost to follow-up 
16 women 
(1.6%) 
with CIN 2
5 women  
(0.5%) 
with CIN 3
2 women (0.2%) 
with invasive 
cancer
824 women 
(80.3%) 
NED*
179 women 
(17.5%) 
with CIN 1
12 women had 
invasive cancer 
Treatment of 
invasive cancer 
Figure 1 Flow chart of study procedures and results. *NED: no evidence of disease (cured).
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sinformation on the effectiveness of cryotherapy, provided by
trained nurses in field conditions in developing countries. In
Thailand, nurses provided cryotherapy for VIA-positive women
in a study evaluating ‘single visit approach’ (SVA), but the
histological nature of the treated lesions was not available as
colposcopy and biopsy were not provided in this study (Royal Thai
College of Obstetricians and Gynaecologists (RTCOG)/JHPIEGO
Corporation Cervical Cancer Prevention Group et al, 2003).
However, combining VIA and cryotherapy in a single sitting was
found to be feasible, safe and acceptable to women (Royal Thai
College of Obstetricians and Gynaecologists (RTCOG)/JHPIEGO
Corporation Cervical Cancer Prevention Group et al, 2003).
Our experience indicates that four-fifths of women treated using
cryotherapy by nurses were cured and cure rates for those
with high-grade CIN lesions were significantly lower than those for
low-grade lesions. Our overall cure rate was slightly lower than the
summary 89.5% overall cure rate found in a recent review of 32
studies (seven randomised controlled trials and 25 case studies)
predominantly conducted in developed countries and in which
cryotherapy was provided by experienced doctors; higher cure
rates were found for CIN 1 lesions, smaller lesions and among
those included in randomised trials; less than 20% of the women
were lost to follow-up in studies included in this review (Alliance
for Cervical Cancer Prevention, 2003). The somewhat lower cure
rates for cryotherapy by nurses in our study may be due to a
number of reasons. More stringent assessment of lesions at
follow-up as evidenced by the fact three out of five evaluated
women had a biopsy possibly resulted in a large proportion of
failures correctly established. Essentially prevalent lesions among
our previously unscreened women were treated. There might be
a learning curve in effectively providing the treatment.
We observed side effects and complications following cryo-
therapy in only a negligible proportion of women in our study
and none were major or life threatening, which is similar to those
reported in other studies (Alliance for Cervical Cancer Prevention,
2003). Our results indicate that ‘see and treat’ cryotherapy
provided by nurses in field conditions is safe and acceptable to
women and support the fact that one can safely direct biopsy
before giving cryotherapy as evidenced by the very low frequency
of delayed bleeding from the biopsy site. Biopsies directed before
cryotherapy provide a safeguard against freezing and leaving
occult invasive cancers without further intervention.
In summary, from a public health perspective, our results
have important implications for cervical cancer screening pro-
grammes in developing countries. Our results provide important
evidence that adequately trained nurses can be used to deliver
colposcopy and cryotherapy services in cervical screening
programmes and are important, reliable, and efficient alternate
human resources. However, the quality of their inputs and
outcome should closely and continuously be monitored to ensure
good quality services.
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